Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X:
“Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS also with ropeg in PROUD/CONTI-PV as with rux in MAJIC-PV.”
Source: Prithviraj Bose/X
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X:
“Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS also with ropeg in PROUD/CONTI-PV as with rux in MAJIC-PV.”
Source: Prithviraj Bose/X